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Introduction
Newborns are a population in which antibiotic usage is
extremely high.
Objectives
The aim of this study was an assessment of antibiotic
usage in BSI treatment in the Polish Neonatology Surveil-
lance Network (PNSN) and determining the possibility of
applying this kind of analysis in infection control.
Methods
Data were collected between 01.01.2009 and 12.31.2013
in five tertiary academic neonatal intensive care units
(NICU) that took part in the PNSN. The PNSN is a pro-
spective national surveillance system for the most rele-
vant infections in the group of very low birth weight
(birth weight <1500 g, VLBW) infants in Poland.
Case BSI patients (both: early- and late-onset) were
defined according to Gastmeier et al. [1] with modifications.
Results
The total duration of antibiotic therapy for 773 cases of
BSI, which are incorporated into the present analysis,
amounted to 14 056 DOTs or 381.6 DDDs.
The median length of antibiotic therapy for a single case
of BSI, regardless of microbiological confirmation or its
lack, amounted to 8 days; whereas the median consump-
tion expressed in DDD was 0.13. In the case of LC-BSI,
median DOT was 8 days, and consumption – 0.12 DDD.
Median length of therapy was shorter for unconfirmed
cases: 7 days, while the consumption of antibiotics was
higher – 0.14 DDD (p<0.0001). High consumption of
glycopeptideds expressed in DOTs was observed in stu-
died population.
Conclusion
Application of classical methods of microbiological diag-
nostics significantly reduces the consumption of antibio-
tics expressed by DDD, however, the high consumption
of glycopeptides indicates the necessity of applying rapid
diagnostic assays.
Nevertheless, the assessment of antibiotic consumption
in neonatal units represents a methodological challenge
and requires the use of different measurement tools.
Analysis of antibiotic consumption is an essential
component of infection control, especially for NICU
patients – for effective planning and reliable evaluation of
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